Maria Giovanna Lizio is an accomplished ISSF Fellow at The University of Manchester, where her interdisciplinary research focuses on the innovative application of bio-photonics and spectroscopic techniques to enhance translational research in clinical settings, particularly for cancer patients. With a robust background in both the...
Maria Giovanna Lizio is an accomplished ISSF Fellow at The University of Manchester, where her interdisciplinary research focuses on the innovative application of bio-photonics and spectroscopic techniques to enhance translational research in clinical settings, particularly for cancer patients. With a robust background in both the pharmaceutical industry and marketing, Maria brings a unique perspective to her work, bridging the gap between scientific discovery and practical application in healthcare.
Currently, Maria is leading key projects aimed at developing advanced instruments for intraoperative analysis of lung cancer. This pivotal work is designed to facilitate the complete removal of tumors during surgery, ultimately improving patient outcomes and reducing recurrence rates. By collaborating closely with the NHS over the past five years, she has gained invaluable insights into the challenges faced by clinicians and patients alike. This understanding allows her to tailor her research to meet real-world needs, ensuring that her innovations are not only scientifically sound but also clinically relevant.
Maria's expertise in Raman spectroscopy and her skills in teamwork and marketing strategy further enhance her ability to communicate complex scientific concepts to diverse audiences, including healthcare professionals and stakeholders in the pharmaceutical industry. Her commitment to social media marketing and marketing communications enables her to effectively disseminate her findings and raise awareness about the importance of integrating cutting-edge technologies in cancer treatment. Through her work, Maria is not only advancing the field of bio-photonics but also making significant strides toward improving the lives of cancer patients.
